INTRODUCTION
Pain following total knee arthroplasty (TKA) is a major problem, with approximately sixty percent of patients reporting severe pain while moderate pain is reported in approximately thirty percent of patients 1 . Generally, TKA patients receive either narcotic patient-controlled analgesia (PCA) or epidural analgesia. The most common side effects of narcotic usage are nausea and vomiting, which may discourage patients from early postoperative mobilization. Epidural analgesia, on the other hand, may be associated with epidural haematoma with concomitant thromboprophylaxis use. Motor block, another potential adverse effect of epidural analgesia may delay the onset of physiotherapy. Good pain control with minimal side effects allow for more effective post-operative rehabilitation.
Multimodal analgesic strategies are now the preferred protocol to reduce the occurrence of such side effects. Strategies such as intra-articular drug injection, continuous epidural, lumbar plexus and femoral and/or sciatic nerve blocks have resulted in improved in post-operative pain control and reduction in narcotic usage. However, these strategies are not without potential adverse effects such as epidural bleeding (when used with prophylactic anticoagulant therapy), diminished muscle control, urinary retention and nerve damage.
The objective of this study is to compare the combination of periarticular drug injection and PCA to PCA use alone in post TKA patients in terms of post-operative pain relief, total amount of PCA narcotic usage postoperatively, rate of return to normal function (as measured by the degree of active knee flexion and straight leg raising (SLR) tests during postoperative rehabilitation programme), the occurrence of side effects and complications and the length of hospital stay.
MATERIALS AND METHODS
This was a prospective, single-blinded, randomized controlled clinical trial on patients undergoing TKA. The study was carried out in the Orthopaedics wards, operation theatres, and follow-up clinics at Kuala Lumpur University Hospital. The study sample included all patients that were electively admitted to the orthopaedics ward for TKA surgery between October 2006 and July 2007. Inclusion criteria were: age between 45 and 75y; weight between 50kg and 100kg; ability to provide informed consent for and cooperate with the study; unilateral TKA. Exclusion criteria were: major psychological problems; previous drug dependency; allergies to ingredients of the injection or PCA; renal insufficiency; abnormal liver enzymes; history of stroke or major neurological deficit; uncontrolled angina; bilateral TKA; acute or chronic knee infection; and bifascicular cardiac block with a prolonged Q-T interval.
The sample size needed was estimated by calculating the standard difference (mean divided by the standard deviation) with reference to a previous study (21.6ml/25ml=0.86) 1 . With the sample power of 0.80, the straight line was across number 45 on the normogram. Although, we calculated that the minimum sample size was 23 patients for each group (46 total), due to unavailability of the primary surgeons for continuation of the study, only 45 patients were recruited into this study during the 10 month recruitment period. Patients were divided into two groups (Standard Group receiving PCA = Group S; Injection Group receiving periarticular injection plus PCA = Group I) via simple random sampling. In order to minimize differences between the two groups due to other factors, the following protocol was followed. A standardized general anaesthesia was used for all patients and patients in both groups also received Celebrex 400 mg and Paracetamol 1000 mg QID, one day prior to the operation. All arthroplasties were performed using a midvastus arthrotomy with cord sparing technique performed by the two surgeons of the Joint Replacement Unit at Kuala Lumpur University hospital (who are directly involved in this study). Third, the periarticular injection was prepared by the anaesthetist and contained 100ml of 0.2% Ropivacaine (Naropin), mixed with 30 mg of Ketorolac (Toradol) and 0.5 ml of Adrenaline (1:1000 dilution). Injections were given intra-operatively before the prosthesis implantation. Sixty ml was injected into the posterior capsule, medial collateral ligament & lateral collateral ligament, and 40 ml into the quadriceps, retinacular tissues, & surrounding soft tissues. Postoperatively, all patients received intravenous PCA -1.5 mg bolus of morphine (narcotic) with a lock out of five minutes, and a maximum of fifteen mg/hour for 48 hours. Oral analgesics (Celebrex 200 mg Daily and Tablet Paracetamol 1000 mg QID) were continued until discharge. PCA opioid consumption given was measured at 6, 12, 24 and 48h hours post-operatively and the end result was calculated as total opioid usage was calculated for each subject. Post-operative pain was scored using Visual Analogue Scale (VAS) three times a day until the PCA was taken off, usually by day two post-operation. The Visual Analogue Scale uses a scale from one to ten with one being no pain and ten being the most severe pain. Post-operative active knee flexion and straight leg raising were measured via goniometer on a daily basis Patients were observed for side effects of Ropivacaine (i.e., peri-oral paraesthesia, visual disturbances, hearing problems, dizziness, uncontrolled muscle contraction, convulsion, hypertension, bradycardia, or headache every fifteen minutes in the recovery room, and every four hours for 48h postoperatively. Side effects of narcotics were also noted in the chart (i.e., nausea, vomiting, confusion, constipation, urinary retention, dizziness, sedation, respiratory depression or pruritus). Patient's criteria for discharge were VAS ≤ 2, no signs of symptoms of surgical wound infection and adequate mobility around with or without aids. This study was approved by the institutional ethics committee. Data analysis and interpretation of results were performed utilizing the SPSS software (version 12 for Windows). The Student t-test and chi-square were used to compare continuous and categorical variables, respectively between the two groups. Continuous variables are presented as a mean and standard deviation, and categorical variables are given as frequency and percentage. A value of p=0.05 was considered statistically significant.
RESULTS
Forty five patients were recruited into this study between October 2006 and July 2007, and 15 patients were excluded for various reasons. Six patients refused to give consent to take part in this study, another six patients had combined spinal-epidural anaesthesia for the surgery and continued with epidural anaesthesia postoperatively. Three patients had other indications for surgery; two patients had rheumatoid arthritis and one had osteoarthritis secondary to previous trauma (age, 45y). The mean length of hospital stay postsurgery was 6.1 days for the group I was significantly shorter than in the group S (mean, 7.5 days, p=0.027).
Only 30 patients were available for data analysis ten months after surgery, 15 knees in 15 patients in group I, and 15 knees in 15 patients in group S. Demographic characteristics were comparable between the two groups (Table I) .
Pain Scores
The Injection (I) group had a significantly lower mean VAS for pain at rest and during exercise than did Standard (S) group (14 patients with VAS ≤3 at rest in group I, nine with VAS ≤3 in group S; 12 had VAS ≤3 during exercise in group I, three had VAS ≤3 during exercise in Group S; p=0.021, p=0.041, respectively) on the first postoperative day, as well as a significantly lower score for pain during exercise for the next forty eight hours after surgery (15 patient with VAS during exercise 3 in group I, eight with VAS≤3 during exercise for group S; p=0.011). However, the VAS at rest and during exercise on the day of discharge was similar (Figure 1 & 2) in both groups.
Patient-Controlled Analgesia Usage and Total Opioid Usage A PCA pump with morphine was maintained for more than 72h for 11 patients in group S compared to only four patients in group I. Most patients in group I used the PCA machine less than forty eight hours and one patient in this group had the PCA for only twenty four hours. Five patients in Group I used less than 10.0 mmol/L of opioid via the PCA, and the maximum usage was less than 50.0 mmol/L, while for patients in group S, the lowest opioid usage was 12.0 mmol/L and the maximum usage was 81.4 mmol/L. Five patients in this group used more than 50.0 mmol/L of opioids ( Figure 3) . The average total opioid consumption was significantly lower in group I y (22.87 mmol/L for Group I compared with 39.78 mmol/L for group S; p = 0.026).
Return of Function
The patients in group I showed better results than those in group S for the amount of active knee flexion on day three post-operation. All of them were able to flex their knee at least ninety degree without much pain (p=0.023). There were four patients in the group S who did not get 90°of knee flexion till the day they were discharged. However, the findings in the straight leg raising test showed no significant difference between the two groups.
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Side Effects of Pharmacotherapy
Seven patients in the Injection group experience nausea vomiting and/or sedation while 15 had such symptoms in the Standard group, although not a statistically significant difference between the two groups. Dizziness was noted in only one patient (in the Injection group) for the entire study. (Figure 4 ). There were no other side effects of narcotics noted during the conduct of this study. Additionally, there were no complications related to the Ropivacaine infiltration reported. The infiltrated dose was generally higher than the manufacturer's recommended maximum dosage of 3 mg/kg (average, 2.8+/-0.6 mg/kg; range, 2.2 mg/kg to 3.4 mg/kg).
DISCUSSION
This study explored means by which surgeons can reduce pain and achieve a speedy recovery after TKA. Our findings are consistent with the results of two recent similar studies; both studies assessed periarticular infiltration with Ropivacaine, Ketorolac, and Adrenaline, although Busch et al 2 added epimorphine to the solution and Vendittoli et al The three active substances of the infiltration mixture used for this study were Ropivacaine, Ketorolac, and Adrenalin. Ropivacaine is pharmacologically similar to Bupivacaine but is associated with less cardiac and central nervous system toxicity, thus allowing patients to tolerate a larger dose 4 . The addition of epinephrine helps to reduce the toxicity of the local anaesthetic by slowing drug release into the circulation. The maximum tolerated doses of local anaesthetics with adrenaline administered periarticularly or by infiltration are not properly established 5 . Our patients received a dose of two hundred mg Ropivacaine injected into periarticular tissues. No patients reported tinnitus, tingling, peri-oral numbness, or other toxic symptoms of local anaesthetics. Several studies have shown that NSAIDs have a clinically relevant peripheral action, and that infiltration or injection provides better pain relief than intravenous administration 5 .
To this end, we added Ketorolac to the periarticular solution. It is also established that peripheral opioid receptors are induced by inflammation 6 . Results demonstrated better pain control during the first 48h post-operation for the Injection group patients, as reflected in the reduction of the mean total opioid consumption via the PCA machine in the Injection group as compared to the Standard group. Most patients in this study used the PCA machine for less than 48h. Although resting pain scores for TKA patients in both groups on the second postoperative day was not statistically different between the two groups, activity pain scores were significantly better in the Injection group. This allowed for (statistically significant) better physical therapy performance in Group I as measured by knee flexion; however, the findings in the straight leg raising test were not statistically significantly different between the two groups. Of note, the patients in Group I were able to perform the straight leg raising exercise at an earlier postoperative point in time than patients in Group I. Improved pain control and mobility allowed for a significant reduction in length of hospital stay in Group I over Group S. The possibility exists that the shortened length of stay in the Injection group patients could at least partially attributed to changes in patient expectations, as more emphasis was placed on early discharge for them. It is fair to say that this variable was not completely controlled for in our study.
We were able to demonstrate a subtle change in postoperative nausea and vomiting (PONV). More specifically, the number of patients experiencing nausea was similar in both groups but significantly fewer patients experienced vomiting in the Injection group, although no effort was made to grade the severity of these side effects. PONV is a multifactorial problem that, in this study, did have a modest correlation with total amount of opioid consumption.
The weaknesses in this study include the mall number of participating patients and the fact that only the patients were blinded for data variables assessment (study staff were aware of the group assignments). Some of the parameters may have had more significant differences if we were able to recruit more patients.
CONCLUSION
In conclusion, infiltration with Ropivacaine as part of the multimodal drug regime including standard postoperative PCA protocol demonstrated a good quality of analgesia after TKA, without increased risks. This study provides statistically significant findings in terms of pain score, early rehabilitation progress, fewer complications and shorter hospital stay, and also that the combination of peri-operative analgesia, post operative pain management and rapid mobilization may be effective in accelerating functional recovery from TKA.
